|
Market Closed -
OTC Markets
14:26:43 2024-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 3.220 USD | -2.13% |
|
-.--% | - |
| 24-12-23 | Guardion Health Sciences, Inc. Declares Cash Dividend, Payable on or Before December 27, 2024 | CI |
| 24-10-15 | Guardion Health Sciences, Inc.(NasdaqCM:GHSI) dropped from S&P TMI Index | CI |
| Market Cap | 4.35M 3.74M 3.52M 3.21M 6M 414M 6.03M 41.74M 16.13M 211M 16.32M 15.97M 668M | P/E 2022 |
-0.51x | P/E 2023 | 42.9x |
|---|---|---|---|---|---|
| Enterprise Value | -2.01M -1.73M -1.63M -1.49M -2.78M -192M -2.79M -19.33M -7.47M -97.57M -7.56M -7.39M -309M | EV / Sales 2022 |
-0.16x | EV / Sales 2023 | 0.04x |
| Free-Float |
98.7% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -2.13% |
| 3 years | 3.04 |  | 18 |
| 5 years | 3.04 | | 99 |
| 10 years | 3.04 | | 1,200 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Goldstone
CEO | Chief Executive Officer | 62 | 2024-10-17 |
| Corporate Secretary | 74 | - | |
Susan Klein
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 2020-06-30 | |
Mark Goldstone
BRD | Director/Board Member | 62 | 2015-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/26/24 | Sell | 115,540 | 8.9973% | |||
| 3/28/24 | Great Point Capital LLC
| Other | Company | 159,652 | 12.5194% | |
| 6/30/23 | Free | Director | 334 | 0.0264% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.13% | -.--% | -.--% | -58.80% | 4.35M | |
| +0.03% | -3.09% | +49.77% | +91.69% | 1,002B | |
| -0.76% | -2.95% | +50.93% | +66.34% | 644B | |
| +0.86% | -4.13% | +19.24% | +68.37% | 443B | |
| -0.42% | -2.92% | +30.06% | +36.31% | 343B | |
| +1.67% | -13.84% | +12.31% | +28.12% | 262B | |
| +0.05% | -4.01% | -2.14% | +11.02% | 245B | |
| -0.48% | -11.65% | +39.75% | +50.82% | 212B | |
| +0.42% | -4.31% | -17.83% | -57.81% | 199B | |
| -0.68% | -2.65% | +25.82% | +91.64% | 181B | |
| Average | -0.28% | -4.62% | +20.79% | +32.77% | 352.97B | |
| Weighted average by Cap. | -0.11% | -4.24% | +32.22% | +57.58% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 11.05M 9.51M 8.95M 8.16M 15.26M 1.05B 15.32M 106M 41.01M 536M 41.49M 40.59M 1.7B | 12.25M 10.54M 9.92M 9.04M 16.92M 1.17B 16.99M 118M 45.46M 594M 45.99M 44.99M 1.88B |
| Net income | -14.92M -12.84M -12.09M -11.02M -20.61M -1.42B -20.69M -143M -55.38M -723M -56.03M -54.82M -2.29B | 158K 136K 128K 117K 218K 15.04M 219K 1.52M 587K 7.66M 593K 581K 24.27M |
| Net Debt | -10.65M -9.17M -8.63M -7.86M -14.71M -1.01B -14.77M -102M -39.53M -516M -40M -39.13M -1.64B | -6.36M -5.47M -5.15M -4.7M -8.78M -605M -8.82M -61.07M -23.6M -308M -23.88M -23.36M -977M |
Employees
9
Sector
Pharmaceuticals
- Stock Market
- Stocks
- GHSI Stock
Select your edition
All financial news and data tailored to specific country editions
